Anxiolytics for Bronchodilation: Refinements to GABA Agonists for Asthma Relief.
作者信息
Nayak Ajay P, An Steven S
机构信息
Center for Translational Medicine.
Department of Medicine Thomas Jefferson University Philadelphia, Pennsylvania.
出版信息
Am J Respir Cell Mol Biol. 2022 Oct;67(4):419-420. doi: 10.1165/rcmb.2022-0287ED.
Abstract
摘要
相似文献
1
Anxiolytics for Bronchodilation: Refinements to GABA Agonists for Asthma Relief.用于支气管扩张的抗焦虑药：用于缓解哮喘的γ-氨基丁酸（GABA）激动剂的改进
Am J Respir Cell Mol Biol. 2022 Oct;67(4):419-420. doi: 10.1165/rcmb.2022-0287ED.
2
The GABAA-BZR complex as target for the development of anxiolytic drugs.GABAA-BZR 复合物作为开发抗焦虑药物的靶点。
Curr Top Med Chem. 2012;12(4):254-69. doi: 10.2174/1568026799078787.
3
[Anxiolytics: Appropriate Use of Benzodiazepine Receptor Agonists].[抗焦虑药：苯二氮䓬受体激动剂的合理使用]
Brain Nerve. 2023 May;75(5):585-590. doi: 10.11477/mf.1416202383.
4
The Case for Cannabinoid CB1 Receptors as a Target for Bronchodilator Therapy for β-agonist Resistant Asthma.大麻素 CB1 受体作为β-激动剂抵抗性哮喘支气管扩张治疗靶点的理由。
Curr Drug Targets. 2018;19(11):1344-1349. doi: 10.2174/1389450118666170615101220.
5
Anxiolytics: past, present, and future agents.抗焦虑药：过去、现在及未来的药物
J Clin Psychiatry. 2003;64 Suppl 3:3-6.
6
Scopoletin ameliorates anxiety-like behaviors in complete Freund's adjuvant-induced mouse model.瑞香素可改善完全弗氏佐剂诱导的小鼠模型的焦虑样行为。
Mol Brain. 2020 Feb 4;13(1):15. doi: 10.1186/s13041-020-0560-2.
7
Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma.可溶性鸟苷酸环化酶作为哮喘支气管扩张剂治疗的替代靶点。
Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):E2355-62. doi: 10.1073/pnas.1524398113. Epub 2016 Apr 11.
8
GABA-A receptors: a viable target for novel anxiolytics?γ-氨基丁酸A受体：新型抗焦虑药的可行靶点？
Curr Opin Pharmacol. 2006 Feb;6(1):24-9. doi: 10.1016/j.coph.2005.08.005. Epub 2005 Dec 15.
9
Anxioselective anxiolytics: on a quest for the Holy Grail.选择性焦虑症治疗药物：追寻圣杯。
Trends Pharmacol Sci. 2012 Nov;33(11):611-20. doi: 10.1016/j.tips.2012.08.003. Epub 2012 Sep 14.
10
Exploring the sites and kinetics of bronchodilator response to -2 agonists in asthma.探讨哮喘患者对β2 激动剂支气管舒张反应的部位和动力学。
J Appl Physiol (1985). 2021 Apr 1;130(4):1106-1113. doi: 10.1152/japplphysiol.00643.2020. Epub 2021 Jan 14.
引用本文的文献
1
Insights and progress on the biosynthesis, metabolism, and physiological functions of gamma-aminobutyric acid (GABA): a review.γ-氨基丁酸（GABA）的生物合成、代谢及生理功能的研究进展与见解：综述
PeerJ. 2024 Dec 16;12:e18712. doi: 10.7717/peerj.18712. eCollection 2024.
2
Airway smooth muscle in contractility and remodeling of asthma: potential drug target mechanisms.气道平滑肌在哮喘中的收缩性和重塑：潜在的药物靶点机制。
Expert Opin Ther Targets. 2023 Jan;27(1):19-29. doi: 10.1080/14728222.2023.2177533. Epub 2023 Feb 13.
本文引用的文献
1
Imidazobenzodiazepine PI320 Relaxes Mouse Peripheral Airways by Inhibiting Calcium Mobilization.咪唑并苯并二氮䓬类化合物 PI320 通过抑制钙动员松弛小鼠外周气道。
Am J Respir Cell Mol Biol. 2022 Oct;67(4):482-490. doi: 10.1165/rcmb.2022-0084OC.
2
Development of Inhaled GABA Receptor Modulators to Improve Airway Function in Bronchoconstrictive Disorders.开发吸入性γ-氨基丁酸受体调节剂以改善支气管收缩性疾病的气道功能。
ACS Pharmacol Transl Sci. 2022 Feb 1;5(2):80-88. doi: 10.1021/acsptsci.1c00238. eCollection 2022 Feb 11.
3
OGR1-dependent regulation of the allergen-induced asthma phenotype.OGR1 依赖性调控变应原诱导的哮喘表型。
Am J Physiol Lung Cell Mol Physiol. 2021 Dec 1;321(6):L1044-L1054. doi: 10.1152/ajplung.00200.2021. Epub 2021 Oct 20.
4
Regulation of ovarian cancer G protein-coupled receptor-1 expression and signaling.调控卵巢癌 G 蛋白偶联受体-1 的表达和信号转导。
Am J Physiol Lung Cell Mol Physiol. 2019 May 1;316(5):L894-L902. doi: 10.1152/ajplung.00426.2018. Epub 2019 Feb 6.
5
Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines.质子敏感受体 OGR1 受苯二氮䓬类药物的偏倚信号转导。
FASEB J. 2018 Feb;32(2):862-874. doi: 10.1096/fj.201700555R. Epub 2018 Jan 4.
6
GABA receptor α-subunit knockout enhances lung inflammation and airway reactivity in a murine asthma model.GABA受体α亚基敲除增强小鼠哮喘模型中的肺部炎症和气道反应性。
Am J Physiol Lung Cell Mol Physiol. 2017 Aug 1;313(2):L406-L415. doi: 10.1152/ajplung.00107.2017. Epub 2017 May 4.
7
Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments.新型哮喘治疗药物——γ-氨基丁酸A型受体亚型选择性咪唑并苯二氮䓬类药物的研发
Mol Pharm. 2016 Jun 6;13(6):2026-38. doi: 10.1021/acs.molpharmaceut.6b00159. Epub 2016 May 10.
8
Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65.药理学上沉默受体GPR68和GPR65的变构配体。
Nature. 2015 Nov 26;527(7579):477-83. doi: 10.1038/nature15699. Epub 2015 Nov 9.
9
Targeting the γ-Aminobutyric Acid A Receptor α4 Subunit in Airway Smooth Muscle to Alleviate Bronchoconstriction.靶向气道平滑肌中的γ-氨基丁酸A受体α4亚基以减轻支气管收缩
Am J Respir Cell Mol Biol. 2016 Apr;54(4):546-53. doi: 10.1165/rcmb.2015-0176OC.
10
Selective targeting of the α5-subunit of GABAA receptors relaxes airway smooth muscle and inhibits cellular calcium handling.选择性靶向γ-氨基丁酸A（GABAA）受体的α5亚基可舒张气道平滑肌并抑制细胞内钙处理。
Am J Physiol Lung Cell Mol Physiol. 2015 May 1;308(9):L931-42. doi: 10.1152/ajplung.00107.2014. Epub 2015 Feb 6.
Zotero 插件